Abstract: A respiratory disease analytics system provides respiratory disease risk reports to a patient, provider, or third-party entity describing a patient's risk of experiencing a medication usage event given data in a geographic region. Regional data, including air pollutant conditions, weather conditions, demographic information, built environment factors, and regional health conditions for a geographic region are accessed from other sources and assigned based on event data recorded during a medicament usage event, as collected by sensors associated with the patient's medicament device/s. The regional data is assigned to medicament usage events occurring within a period of time. The assigned regional data is analyzed to determine an expected number of medication usage events for the geographic region occurring over the period of time.

Abstract: A system and method for providing chronic obstructive pulmonary disease (COPD) exacerbation risk notifications in real time or near-real time is described. Rescue and controller medication events are detected by sensors associated with the patient's medicament device/s, and provide a basis to determine to rescue and controller medication use trends for the patient. This data is analyzed to determine the patient's risk for COPD exacerbation after each event, and is used to send notifications to one or both of the patient and their health care provider.

Abstract: A system and method to match an interface to the face of a user for respiratory therapy. A facial image of the user is stored. Facial features based on the facial image are determined. A database stores facial profiles based on facial features and a corresponding plurality of interfaces. A database stores operational data of respiratory therapy devices with the plurality of corresponding interfaces. A selection engine is coupled to the databases. The selection engine is operative to select an interface for the user from the plurality of corresponding interfaces based on a desired outcome based on the stored operational data and the facial features. The collected data may also be employed to determine whether the selected interface is correctly fitted to the face of the user.

Abstract: A patient interface includes: a plenum chamber; a seal-forming structure; a positioning and stabilising structure; a plenum chamber insert configured to be positioned and retained within the plenum chamber; and a vent structure; wherein the plenum chamber insert has a plenum chamber insert port; wherein the plenum chamber insert has an exterior surface configured to be positioned adjacent to an interior surface of the plenum chamber; wherein when the plenum chamber insert is positioned and retained within the plenum chamber, a radial channel is formed by the interior surface of the plenum chamber and the exterior surface of the plenum chamber insert such that gas is able to pass between a patient-proximal side of the plenum chamber insert and a patient-distal side of the plenum chamber insert via the radial channel during use.

Abstract: A system and method to determine a sleep disorder in a patient is disclosed. A storage device stores a digital image including a face and a neck of the patient. A database stores previously identified phenotypes and dimensions of facial and neck features. A sleep disorder analysis engine is coupled to the storage device and the database. The sleep disorder analysis engine is operable to identify features of the face and the neck from the image by determining landmarks on the image. The sleep disorder analysis engine classifies at least one phenotype from the image based on comparisons with the database. The sleep disorder analysis engine correlates the at least one phenotype and at least one feature with a sleep disorder. The sleep disorder analysis engine determines a risk score of the sleep disorder based on the correlation of the phenotype and the feature.

Abstract: A method includes displaying a first real-time video of at least a portion of a face of a user, at least a portion of a head of the user, or a combination of the at least a portion of the face and the at least a portion of the head of the user. The first real-time video is modified by superimposing a virtual user interface. A second real-time video of at least a portion of a face of a user, at least a portion of a head of the user, or a combination of the at least a portion of the face and the at least a portion of the head of the user is displayed. The user in the second real-time video wearing a physical user interface. Feedback is provided to the user in real time on the second real-time video.

Abstract: A method and system for determining a comfort score to evaluate an interface to be worn on a face of a user of a respiratory therapy device. Facial features of the user are determined based on a facial image. Facial feature data from a user population and a corresponding set of interface dimensional data from interfaces used by the user population is stored. Operational data of respiratory therapy devices used by the user population with the interfaces is stored. A comfort score for the interface is determined via an evaluation tool. The evaluation tool determines the comfort score based on the facial features of the user, the output of a simulator simulating the interface on the plurality of facial feature data, and the operational data. The comfort score is displayed on a display to assist a user in selection of an interface with the best comfort.

Abstract: A respiratory disease analytics system provides respiratory disease risk reports to a patient, provider, or third-party entity describing a patient's risk of experiencing a medication usage event given data in a geographic region. Regional data, including air pollutant conditions, weather conditions, demographic information, built environment factors, and regional health conditions for a geographic region are accessed from other sources and assigned based on event data recorded during a medicament usage event, as collected by sensors associated with the patient's medicament device/s. The regional data is assigned to medicament usage events occurring within a period of time. The assigned regional data is analyzed to determine an expected number of medication usage events for the geographic region occurring over the period of time.

Abstract: This description relates to insight into the asthma management habits of a patient or a plurality of patients. The provided information includes records of rescue medication usage events, records of controller medication events, and overall evaluations of a patients disease management. Users of the application may include both patients who may use the information to monitor their own habits or providers who may use the information to monitor patients or improve a patient's existing medication regimen.

Abstract: This description provides risk notifications for a geographic region to inform patients and effect behavior changes to prevent rescue events and exacerbations from occurring. A risk analysis for a geographic region is based on data gathered from a population of patients who may experience respiratory events within the geographic region. Rescue medication events, environmental conditions relevant to the rescue medication events, and other contextually relevant information are detected by sensors associated with a population of patients' medicament device/s and are collected from other sources, respectively, to provide a basis to determine a risk score. This data is analyzed to determine the severity of the risk of a respiratory event occurring within a geographical region and accordingly sending a notification to patients within that geographical region.

Abstract: The invention relates to a vent structure for a respiratory therapy system. In one form the vent structure comprises a vent housing, and a plurality of partitions inside the vent housing forming therebetween a plurality of vent slots. The vent slots comprise a vent inlet configured to receive an air flow, and a vent outlet configured to allow the air flow to exit into the surrounding ambient air. The partitions may be formed such that each vent slot has a smaller cross-sectional area at a first region closer to the vent inlet than a second region. The vent structure may comprise a plurality of deflectors configured to deflect the air flow through each vent slot towards a part of the vent housing and/or another component in the respiratory system. The vent structure may comprise a projecting portion extending outwardly from the vent outlet to inhibit generation of flow layer instabilities.

Abstract: The invention relates to a connection member configured to connect an air circuit to a patient interface to convey a flow of pressurised breathable gas. The connection member comprises: first and second tube portions configured to connect to a patient interface and air circuit respectively; an anti-asphyxia valve (AAV); and a vent for venting gas exhaled by the patient to the ambient air. The vent is formed between the first and second tube portions. The first tube portion may have a substantially straight first longitudinal central axis and the second tube portion may have a substantially straight second longitudinal central axis that is substantially straight, the first tube portion and the second tube portion being arranged with the first longitudinal central axis substantially parallel to the second longitudinal central axis. The AAV is located in a position on the connection member closer to the patient interface than the vent.

Abstract: A system and method for providing chronic obstructive pulmonary disease (COPD) exacerbation risk notifications in real time or near-real time is described. Rescue and controller medication events are detected by sensors associated with the patient's medicament device/s, and provide a basis to determine to rescue and controller medication use trends for the patient. This data is analyzed to determine the patient's risk for COPD exacerbation after each event, and is used to send notifications to one or both of the patient and their health care provider.

Abstract: A system and method to determine whether a patient should receive enhanced treatment of a respiratory ailment such as the prescription of biologics. Use data of a respiration medicament device to deliver controller or rescue respiration medicament to the patient is collected. The use data is transmitted to a storage device. The use data is stored in the storage device. Based on the use data, the system determines whether the patient is over a first threshold level of adherence in use of the respiration medicament device. Based on the use data, the system determines whether the patient has a rescue respiration medicament use over a second threshold level. A notification of recommendation of the enhanced treatment is provided if the patient is over the first and the second threshold.

Abstract: Apparatus and methods automate selection of patient interface(s). Image data captured by an image sensor may contain facial feature(s) of a user. The facial features may be captured in association with a predetermined reference feature of known dimension(s) such as with a user interface display that is generated with a sequence of icons that are activated for directing and tracking movement within the interface for desired image capture. The user's facial feature(s) and the reference feature may be detected in the captured image data. The image may be processed to measure an aspect of the detected facial feature(s) based on the reference feature. A patient interface size may be detected from standard patient interface sizes based on a comparison between the measured aspect of the facial feature(s) and a data record relating sizing information of the standard patient interface sizes and the measured aspect of the facial feature(s).

Abstract: This description relates to insight into the asthma management habits of a patient or a plurality of patients. The provided information includes records of rescue medication usage events, records of controller medication events, and overall evaluations of a patients disease management. Users of the application may include both patients who may use the information to monitor their own habits or providers who may use the information to monitor patients or improve a patient's existing medication regimen.

Abstract: A patient interface includes: a plenum chamber; a seal-forming structure; a positioning and stabilising structure; a plenum chamber insert configured to be positioned and retained within the plenum chamber; and a vent structure; wherein the plenum chamber insert has a plenum chamber insert port; wherein the plenum chamber insert has an exterior surface configured to be positioned adjacent to an interior surface of the plenum chamber; wherein when the plenum chamber insert is positioned and retained within the plenum chamber, a radial channel is formed by the interior surface of the plenum chamber and the exterior surface of the plenum chamber insert such that gas is able to pass between a patient-proximal side of the plenum chamber insert and a patient-distal side of the plenum chamber insert via the radial channel during use.

Abstract: Systems and methods for monitoring accurate, real-time medicament device events, performing analytics on that data, and providing notifications are described. In various embodiments, an application server receives controller medication events, analyzes the events, associated event times, and controller medication dosage plans to characterize event times and send notifications for future doses. The controller medication dosage plan may specify a dose time for a planned dose, a narrow time window comprising the dose time, and an expanded time window comprising the narrow time window and longer in duration than the narrow time window, and the events may be characterized based on their time relative to the dose time, the time windows, and other events.

Abstract: This description provides trigger identification notifications to patients suffering from respiratory diseases based on large amounts of patient data in order to help effect behavior changes in a patient to prevent inhaler rescue usage events from occurring. Rescue medication events, environmental conditions, and other contextually relevant patient information are detected by sensors associated with the patient's medicament devices and are collected from other sources, respectively to provide a basis to determine identify various triggers of recue inhaler usage events for a patient. Each trigger is analyzed to determine the severity of the patient's reaction to the trigger and is used to send notifications accordingly.

Abstract: The technology relates to a vent for a respiratory therapy system. The vent comprises a vent body having formed therein a plurality of slots allowing a vent flow of exhaled gases to ambient. The slots have a length, a width and a height. In examples the width of each slot is significantly greater than the height and the slots are arranged such that the widths of the slots extend in mutually parallel directions. The vent body may also be configured so that the length of each slot is significantly greater than the height and/or the outlet area is greater than the inlet area. In examples the vent is provided with a cover and an actuator to move the cover between a first position in which the cover at least partially occludes flow through the vent and a second position in which the degree of occlusion is reduced.